Entry - #607487 - CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25 - OMIM
# 607487

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25


Other entities represented in this entry:

CARDIOMYOPATHY, DILATED, 1N, FORMERLY, INCLUDED; CMD1N, FORMERLY, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q12 Cardiomyopathy, hypertrophic, 25 607487 AD 3 TCAP 604488
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
CARDIOVASCULAR
Heart
- Left ventricular hypertrophy (in some patients)
- Sigmoid septal shape (in some patients)
- Abnormal Q-waves on electrocardiography (in some patients)
- Wolff-Parkinson-White syndrome (rare)
- Sudden cardiac death after exercise (in some patients)
- Myocyte hypertrophy
- Interstitial fibrosis
MOLECULAR BASIS
- Caused by mutation in the titin-CAP gene (TCAP, 604488.0003)
Cardiomyopathy, familial hypertrophic - PS192600 - 37 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p31.1 Cardiomyopathy, hypertrophic, 20 AD 3 613876 NEXN 613121
1q32.1 Cardiomyopathy, hypertrophic, 2 AD 3 115195 TNNT2 191045
1q43 Cardiomyopathy, dilated, 1AA, with or without LVNC AD 3 612158 ACTN2 102573
1q43 Cardiomyopathy, hypertrophic, 23, with or without LVNC AD 3 612158 ACTN2 102573
2q31.2 Cardiomyopathy, familial hypertrophic, 9 AD 3 613765 TTN 188840
3p25.3 Cardiomyopathy, familial hypertrophic AD, DD 3 192600 CAV3 601253
3p21.31 Cardiomyopathy, hypertrophic, 8 AD, AR 3 608751 MYL3 160790
3p21.1 Cardiomyopathy, hypertrophic, 13 AD 3 613243 TNNC1 191040
3q27.1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies AR 3 620236 KLHL24 611295
4p12 ?Cardiomyopathy, familial hypertrophic, 30, atrial AR 3 620734 CORIN 605236
4q26 Cardiomyopathy, hypertrophic, 16 AD 3 613838 MYOZ2 605602
6q22.31 Cardiomyopathy, hypertrophic, 18 AD 3 613874 PLN 172405
7p12.1-q21 Cardiomyopathy, hypertrophic, 21 AD 2 614676 CMH21 614676
7q32.1 Cardiomyopathy, familial hypertrophic, 26 AD 3 617047 FLNC 102565
7q32.1 Cardiomyopathy, familial restrictive 5 AD 3 617047 FLNC 102565
7q32.1 Arrhythmogenic right ventricular dysplasia, familial AD 3 617047 FLNC 102565
7q36.1 Cardiomyopathy, hypertrophic 6 AD 3 600858 PRKAG2 602743
10q21.3 Cardiomyopathy, hypertrophic, 22 AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, dilated, 1KK AD 3 615248 MYPN 608517
10q21.3 Cardiomyopathy, familial restrictive, 4 AD 3 615248 MYPN 608517
10q22.2 Cardiomyopathy, hypertrophic, 15 AD 3 613255 VCL 193065
10q23.2 Cardiomyopathy, dilated, 1C, with or without LVNC AD 3 601493 LDB3 605906
10q23.2 Cardiomyopathy, hypertrophic, 24 AD 3 601493 LDB3 605906
10q23.2 Left ventricular noncompaction 3 AD 3 601493 LDB3 605906
11p15.1 Cardiomyopathy, hypertrophic, 12 AD 3 612124 CSRP3 600824
11p11.2 Cardiomyopathy, hypertrophic, 4 AD, AR 3 115197 MYBPC3 600958
12q24.11 Cardiomyopathy, hypertrophic, 10 AD 3 608758 MYL2 160781
14q11.2 Cardiomyopathy, hypertrophic, 14 AD 3 613251 MYH6 160710
14q11.2 Cardiomyopathy, hypertrophic, 1 AD, DD 3 192600 MYH7 160760
15q14 Cardiomyopathy, hypertrophic, 11 AD 3 612098 ACTC1 102540
15q22.2 Cardiomyopathy, hypertrophic, 3 AD 3 115196 TPM1 191010
15q25.3 Cardiomyopathy, familial hypertrophic 27 AR 3 618052 ALPK3 617608
17q12 Cardiomyopathy, hypertrophic, 25 AD 3 607487 TCAP 604488
18q12.2 Cardiomyopathy, familial hypertrophic, 28 AD 3 619402 FHOD3 609691
19q13.42 Cardiomyopathy, hypertrophic, 7 AD 3 613690 TNNI3 191044
20q11.21 Cardiomyopathy, hypertrophic, 1, digenic AD, DD 3 192600 MYLK2 606566
20q13.12 Cardiomyopathy, hypertrophic, 17 AD 3 613873 JPH2 605267

TEXT

A number sign (#) is used with this entry because of evidence that hypertrophic cardiomyopathy-25 (CMH25) is caused by heterozygous mutation in the TCAP gene (604488) on chromosome 17q12.

For a general phenotypic description and a discussion of genetic heterogeneity of hypertrophic cardiomyopathy, see CMH1 (192600).


Clinical Features

Hayashi et al. (2004) studied 2 Japanese families with hypertrophic cardiomyopathy. In the first family, an affected mother and son both showed left ventricular hypertrophy (LVH) on electrocardiography (ECG), and the 62-year-old mother also exhibited Wolff-Parkinson-White syndrome (see 194200) whereas her 29-year-old son had abnormal Q-waves. The mother's father had died suddenly after exercise at 34 years of age. In the second family, a 67-year-old sister and 48-year-old brother had CMH; the sister showed LVH on ECG, whereas the brother had abnormal Q-waves. Two of their sibs had died suddenly after exercise, at 33 and 44 years of age.

Bos et al. (2006) reported a 65-year-old woman who was diagnosed with CMH at 44 years of age and who had massive hypertrophy, with a maximum left ventricular wall thickness of 46 mm. Although she was asymptomatic at presentation, she later developed dyspnea. She was treated with myectomy and a pacemaker. Family history included CMH but not sudden cardiac death. Reporting on the same patient, Theis et al. (2006) noted that she exhibited a sigmoid septal shape and that histopathologic examination of cardiac tissue from the myectomy procedure showed severe myocyte hypertrophy with moderate interstitial fibrosis.


Inheritance

The transmission pattern of CMH25 in the families reported by Hayashi et al. (2004) was consistent with autosomal dominant inheritance.


Molecular Genetics

Following a screen of 10 known CMH-associated genes in 346 patients with CMH, Hayashi et al. (2004) directly sequenced the TCAP gene and identified heterozygosity for 2 different TCAP missense mutations, T137I (604488.0004) and R153H (604488.0005), in 2 Japanese probands who were negative for mutation in the known genes. The mutations, which segregated with disease in each family, were not found in 240 Japanese and 70 Korean controls.

In a cohort of 389 unrelated patients with CMH, Bos et al. (2006) screened for mutations in the 8 CMH-associated myofilament genes and in the 3 Z-disc genes TTN (188840), CSRP3 (600824), and TCAP. A variant was detected in the TCAP gene in 4 of the patients (see, e.g., R70W, 604488.0006).

Reclassified Variants

The R87Q variant (604488.0003) reported by Knoll et al. (2002) in a patient with dilated cardiomyopathy, previously designated in OMIM as CMD1N, has been reclassified as a variant of unknown significance. In a patient with dilated cardiomyopathy, Knoll et al. (2002) identified a heterozygous mutation in the TCAP gene (R87Q; 604488.0003).


REFERENCES

  1. Bos, J. M., Poley, R. N., Ny, M., Tester, D. J., Xu, X., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., Ackerman, M. J. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Molec. Genet. Metab. 88: 78-85, 2006. [PubMed: 16352453, images, related citations] [Full Text]

  2. Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., Koga, Y., Nakamura, H., and 10 others. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44: 2192-2201, 2004. [PubMed: 15582318, related citations] [Full Text]

  3. Knoll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., McKenna, W., Yokoyama, M., and 9 others. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111: 943-955, 2002. [PubMed: 12507422, related citations] [Full Text]

  4. Theis, J. L., Bos, J. M., Bartleson, V. B., Will, M. L., Binder, J., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., Ackerman, M. J. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 351: 896-902, 2006. [PubMed: 17097056, related citations] [Full Text]


Marla J. F. O'Neill - updated : 11/11/2022
Marla J. F. O'Neill - updated : 4/21/2015
Creation Date:
Stylianos E. Antonarakis : 1/16/2003
carol : 03/27/2024
carol : 11/14/2023
carol : 11/11/2022
carol : 08/17/2016
mcolton : 05/26/2015
carol : 4/21/2015
mgross : 1/17/2003
mgross : 1/16/2003

# 607487

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 25; CMH25


Other entities represented in this entry:

CARDIOMYOPATHY, DILATED, 1N, FORMERLY, INCLUDED; CMD1N, FORMERLY, INCLUDED

DO: 0110328;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
17q12 Cardiomyopathy, hypertrophic, 25 607487 Autosomal dominant 3 TCAP 604488

TEXT

A number sign (#) is used with this entry because of evidence that hypertrophic cardiomyopathy-25 (CMH25) is caused by heterozygous mutation in the TCAP gene (604488) on chromosome 17q12.

For a general phenotypic description and a discussion of genetic heterogeneity of hypertrophic cardiomyopathy, see CMH1 (192600).


Clinical Features

Hayashi et al. (2004) studied 2 Japanese families with hypertrophic cardiomyopathy. In the first family, an affected mother and son both showed left ventricular hypertrophy (LVH) on electrocardiography (ECG), and the 62-year-old mother also exhibited Wolff-Parkinson-White syndrome (see 194200) whereas her 29-year-old son had abnormal Q-waves. The mother's father had died suddenly after exercise at 34 years of age. In the second family, a 67-year-old sister and 48-year-old brother had CMH; the sister showed LVH on ECG, whereas the brother had abnormal Q-waves. Two of their sibs had died suddenly after exercise, at 33 and 44 years of age.

Bos et al. (2006) reported a 65-year-old woman who was diagnosed with CMH at 44 years of age and who had massive hypertrophy, with a maximum left ventricular wall thickness of 46 mm. Although she was asymptomatic at presentation, she later developed dyspnea. She was treated with myectomy and a pacemaker. Family history included CMH but not sudden cardiac death. Reporting on the same patient, Theis et al. (2006) noted that she exhibited a sigmoid septal shape and that histopathologic examination of cardiac tissue from the myectomy procedure showed severe myocyte hypertrophy with moderate interstitial fibrosis.


Inheritance

The transmission pattern of CMH25 in the families reported by Hayashi et al. (2004) was consistent with autosomal dominant inheritance.


Molecular Genetics

Following a screen of 10 known CMH-associated genes in 346 patients with CMH, Hayashi et al. (2004) directly sequenced the TCAP gene and identified heterozygosity for 2 different TCAP missense mutations, T137I (604488.0004) and R153H (604488.0005), in 2 Japanese probands who were negative for mutation in the known genes. The mutations, which segregated with disease in each family, were not found in 240 Japanese and 70 Korean controls.

In a cohort of 389 unrelated patients with CMH, Bos et al. (2006) screened for mutations in the 8 CMH-associated myofilament genes and in the 3 Z-disc genes TTN (188840), CSRP3 (600824), and TCAP. A variant was detected in the TCAP gene in 4 of the patients (see, e.g., R70W, 604488.0006).

Reclassified Variants

The R87Q variant (604488.0003) reported by Knoll et al. (2002) in a patient with dilated cardiomyopathy, previously designated in OMIM as CMD1N, has been reclassified as a variant of unknown significance. In a patient with dilated cardiomyopathy, Knoll et al. (2002) identified a heterozygous mutation in the TCAP gene (R87Q; 604488.0003).


REFERENCES

  1. Bos, J. M., Poley, R. N., Ny, M., Tester, D. J., Xu, X., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., Ackerman, M. J. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Molec. Genet. Metab. 88: 78-85, 2006. [PubMed: 16352453] [Full Text: https://doi.org/10.1016/j.ymgme.2005.10.008]

  2. Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., Koga, Y., Nakamura, H., and 10 others. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44: 2192-2201, 2004. [PubMed: 15582318] [Full Text: https://doi.org/10.1016/j.jacc.2004.08.058]

  3. Knoll, R., Hoshijima, M., Hoffman, H. M., Person, V., Lorenzen-Schmidt, I., Bang, M.-L., Hayashi, T., Shiga, N., Yasukawa, H., Schaper, W., McKenna, W., Yokoyama, M., and 9 others. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 111: 943-955, 2002. [PubMed: 12507422] [Full Text: https://doi.org/10.1016/s0092-8674(02)01226-6]

  4. Theis, J. L., Bos, J. M., Bartleson, V. B., Will, M. L., Binder, J., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., Ackerman, M. J. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 351: 896-902, 2006. [PubMed: 17097056] [Full Text: https://doi.org/10.1016/j.bbrc.2006.10.119]


Contributors:
Marla J. F. O'Neill - updated : 11/11/2022
Marla J. F. O'Neill - updated : 4/21/2015

Creation Date:
Stylianos E. Antonarakis : 1/16/2003

Edit History:
carol : 03/27/2024
carol : 11/14/2023
carol : 11/11/2022
carol : 08/17/2016
mcolton : 05/26/2015
carol : 4/21/2015
mgross : 1/17/2003
mgross : 1/16/2003